• HOME
  • TFOS DEWS II REPORT
  • SPONSORS
logo
  • HOME
  • TFOS DEWS II REPORT
  • SPONSORS
  • HOME
  • TFOS DEWS II REPORT
  • SPONSORS
    • ALCON
    • NOVARTIS
    • SHIRE
    • ALLERGAN
    • BAUSCH + LOMB
    • AKORN
    • COOPER VISION
    • DOMPÈ
    • HORUS
    • LUBRIS
    • OCULEVE
    • SUN PHARMA
    • TEAR LAB
    • THEA
    • SIFI
    • JOHNSON & JOHNSON
    • ZEISS
    • QUINT HEALTH
    • SCOPE
    • SENJU

TFOS DEWS II - Clinical protocol for dry eye diagnostic test battery

From Section 6, the recommended diagnostic and monitoring test battery is collated in Fig. 5. Symptoms and at least one positive result of the markers of homeostasis listed below should constitute the diagnosis of DED. If a patient has dry eye symptoms, DED is diagnosed when at least one homeostasis test result is positive. This can occur even if the practitioner does not have access to the full battery of recommended tests. However, if the practitioner has access to only a limited number of the homestasis marker tests and these show negative results, a referral may be necessary to confirm the results of the remaining measures, to which the practitioner does not have access, before a diagnosis of DED can be excluded.



Fig. 5 DED diagnostic test battery. The screening DEQ-5 or OSDI confirms that a patient might have DED and triggers diagnostic testing of non-invasive breakup time, osmolarity [measured prior to breakup time if FBUT used] and ocular surface staining with fluorescein and lissamine green (observing the cornea, conjunctiva and eyelid margin). On initial diagnosis, it is important to exclude conditions that can mimic DED with the aid of the triaging questions (Section 9) and to assess the risk factors which may inform management options [380]. Marked symptoms in the absence of clinically observable signs might suggest an element of neuropathic pain. DED is a subset of OSD; signs alone may still warrant management to prevent DED manifestation and to optimise the optical corneal surface such as prior to refractive surgery or contact lens wear [4]. MGD features [483], lipid thickness/dynamics, and tear volume assessment, and their severity inform the subtype classification of DED as predominantly evaporative or predominantly aqueous deficient which helps inform the management of DED. In accordance with the recommendations of the MGD Workshop (2011) [483], MILD MGD is indicated by a secretion grade 4-7, an expressibility grade of 1 and an amorphous/color fringe lipid pattern. MODERATE MGD is indicated by meibomian gland orifice plugging, lid margin vascularity, a secretion grade 8-12, an expressibility grade of 2 and a meshwork or wave (flow) lipid pattern. SEVERE MGD is indicated by lid margin meibomian gland orifice drop-out or displacement, a secretion grade ≥ 13, an expressibility grade of 3 and an absent, globular or abnormal color fringe lipid pattern. Videos of these diagnostic and sub-classification techniques are available on the TFOS website. Sjögren syndrome should be suspected if the DEQ-5 score is > 12. Further testing will help identify treatment mechanisms worthy of targeting, but are beyond the scope of this Diagnostic Methodology report.


In situations where there are chronic symptoms but limited signs, that are refractory to treatment, then neuropathic pain rather than DED should be considered. Asymptomatic patients with DED type signs, unattributable to other conditions via the differential diagnosis and comorbidities triaging questions in Section 9, might still warrant prophylactic ocular surface treatment. Videos of these diagnostic as well as sub-classification techniques of MGD, lipid thickness/dynamics and tear volume are available on the TFOS website (https://www.theocularsurfacejournal.com).

Tables of severity describing several signs and symptoms and (often arbitrary) cut-offs for different levels are of limited use, as features of dry eye often do not show strong association. Hence it is recommended that severity, for the purpose of selecting treatment, is based on subtype classification features (MGD, lipid thickness/dynamics and non-invasive tear volume) along with symptomology.
The recommended order and clinical practice procedural recommendations are as follows:

8.1 Symptoms

DEQ-5 (Fig. 6a) or OSDI (Fig. 6b) – self-administered [35,37]. Positive result is a DEQ-5 score ≥6 [37], or OSDI score ≥13 [35].


Fig. 6aFive-item Dry Eye Questionnaire (DEQ-5) reproduced with permission (Indiana University) [37].

 
Fig. 6b Ocular Surface Disease Index (OSDI©) Version 1 Permission received. Copyright 1995 Allergan Inc. Irvine, CA, USA. All rights reserved.
 
8.2 Tear breakup time

8.2.1 Non-invasive breakup time

Non-invasive breakup time should be performed with a method where as much of the naturally exposed cornea as possible is specularly illuminated with a light source allowing observation of breakup over the whole surface, after a blink. Objective methods are preferred, with three measurements being performed and the median value recorded. Following training, if a patient can no longer refrain from blinking before the tear film breaks up, this is typically counted as the breakup time for that measurement [194]. The lower median breakup value of the two eyes should be considered in making the diagnosis. The cut-off for a positive finding can be as low as 2.7 s for automated algorithms [142], and up to 10 s for subjective observation techniques [134].
8.2.2 FBUT

FBUT can be considered when non-invasive techniques are not available, but due to its more invasive nature, should follow after osmolarity measurement. Fluorescein should be instilled at the outer canthus to avoid ocular surface damage (see Section 8.4.1 for instillation instructions), with the excess saline on the strip shaken off, or a reduced area fluorescein strip used [118]. For optimal results, viewing should take place between 1 and 3 min after instillation [279]. A positive finding has been reported to be a value < 10 s [13] although in some studies the average in healthy middle aged patients is noted to be lower than this [244].

8.3 Osmolarity

Osmolarity should be assessed with a temperature stabilised, calibration checked device. In the case of the Tearlab, temperature stability is achieved by having the device powered on for a sufficient period of time with test cards adjacent to the device for at least 30 min. Seat the patient with chin tilted upward and eyes directed toward the ceiling. Place one hand on the face for stabilization, as appropriate. Do not pull the eyelid down or away from the eye. Sample from just above the lower eyelid tear meniscus, being careful not to press inward to avoid contact with the globe during collection. The difference between the eyes as well as the absolute measures can be diagnostic [170,171]. A positive result is considered to be ≥ 308 mOsm/L with the currently available device in either eye [13,15], or an interocular difference >8 mOsm/L [171].

8.4 Ocular surface staining

8.4.1 Lissamine green staining

Principally for assessing conjunctival and lid margin damage, a lissamine green strip is wet with saline, with the whole drop retained on the strip for at least 5 s to elute the dye. A 10 μL or ∼ ¼ to ½ of a drop appears to be an optimal volume if pipetting a predetermined concentration solution [272,280]. Otherwise, a drop from the strip is instilled inside the far lower temporal lid in upgaze with the lower eyelid of the eye pulled slightly temporally to avoid damage to the conjunctival or lid wiper tissue (Fig. 7). Studies have suggested that observation should occur between 1 and 4 min post-instillation, and that observation through a red filter potentially aids visualization [272,280]. A positive score is > 9 conjunctival spots [285].



Fig. 7 Recommended location to apply ophthalmic dyes in strip form to avoid confounding damage to the conjunctiva and lid margins observed for the diagnosis of DED and its sub-classification. See video on TFOS website for further guidance.
8.4.2 Fluorescein staining

Principally for assessing corneal damage, fluorescein should be instilled in a similar way, but with the excess saline on the strip shaken off to instil a minimal volume. Optimal viewing is between 1 and 3 min after instillation [279]. A positive result is > 5 corneal spots [285].

Lid wiper epitheliopathy can be observed stained with fluorescein, rose bengal or lissamine green dyes, although there seems to be a preference for just lissamine green in recent research, with viewing recommended 3–6 min after repeat instillation using 2 separate strips wet with 2 saline drops [484]. Positive is LWE of ≥ 2 mm in length and/or ≥ 25% sagittal width (excluding Marx's line) [391].
DED severity can change with the time of day so this should be considered in interpreting results and in monitoring DED over time [485,486].

Tear Film & Ocular Surface Society Boston, MA 02113 USA - © All Rights Reserved.
twitter - youtube - blog - linked in - download the TFOS app on the Appstore - download the TFOS App for Android
Questo sito utilizza cookie di profilazione propri e di siti terzi. Se vuoi saperne di più consula la cookie policy. Chiudendo questo banner acconsenti all'uso dei cookie. Grazie
Ok
Leggi di più